Remdesivir
-
Hetero Healthcare Ltd starts supply of generic Remdesivir
Business | July 15, 2020 12:53 ISTCovifor is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and children, hospitalised with severe symptoms of the disease.
-
Rumours on 'coronavirus vaccine' spread in Mumbai; crowds gather at Ghatkopar store
News | July 11, 2020 21:20 ISTRumours spread in Mumbai on 'coronavirus vaccine'. Following this, people started gathering at a store in Ghatkopar.
-
Indiscriminate use of remdesivir, tocilizumab on COVID-19 patients can cause more harm than good
India | July 11, 2020 20:38 ISTThe Indian Council of Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS) have asked states to use drugs like remdesivir and tocilizumab, mentioned as investigational therapies, on COVID-19 patients strictly as per the laid down protocol as their "indiscriminate use or use in conditions for which they are not desirable may cause more harm than good".
-
Remdesivir linked to reduced death risk in severe COVID-19 patients
World | July 11, 2020 16:26 ISTNew data revealed by Gilead Sciences has shown that its antiviral drug remdesivir reduces death risk of severe Covid-19 patients by as much as 62 per cent when compared with standard care alone.
-
Doctors advised to use Remdesivir on COVID-19 patients strictly under laid-down protocol
India | July 10, 2020 21:29 ISTDoctors in state hospitals are being advised to use antiviral Remdesivir on COVID-19 patients strictly as per protocol amid some reports of liver damage in such patients treated with the drug, official sources said.
-
Shortage of coronavirus medicine Remdesivir in Delhi, Mumbai. What's the latest
India | July 10, 2020 6:56 ISTSeveral cities across India, including Mumbai, Bangalore are reportedly facing a shortage of the experimental antiviral drug Remdesivir. Delhi is also struggling to source it from other cities or buying it at exorbitant prices. In Delhi, both private and government hospitals have reported depleting stock of the coronavirus medicine.
-
How Remdesivir can save lives in nations with lower hospital capacity
Science | July 08, 2020 21:30 ISTAmid news that the US has bought up virtually the entire global supply of remdesivir, a new study outlines how the drug could save lives in countries with a lower hospital capacity, such as South Africa, where Covid-19 is beginning to overwhelm intensive care units (ICUs).
-
Cipla launches generic version of remdesivir in India
Business | July 08, 2020 21:24 ISTPharma major Cipla on Wednesday said it has launched its generic version of antiviral drug remdesivir at a price which is among the lowest globally and is looking to supply over 80,000 vials within the first month.
-
COVID-19: Mylan to launch remdesivir in India at Rs 4,800 per 100 mg vial
Business | July 07, 2020 8:43 ISTThe company joins domestic pharma firm Cipla and Hetero who have already received permission from the Drug Controller General of India (DCGI) to manufacture and market remdesivir for the treatment of COVID-19.
-
US secures almost entire world stock of Covid-19 drug remdesivir
World | July 01, 2020 18:25 ISTThe Donald Trump administration has secured nearly the entire world stock of antiviral drug remdesivir from US-based Gilead Sciences for the next three months, leaving hardly any stock of the key Covid-19 drug for the rest of the world.
-
Hetero set to deliver 20,000 vials of generic Remdesivir
Business | June 24, 2020 16:16 ISTFollowing the approval of Covifor, the generic version of Remdesivir, by the Drug Controller General of India (DCGI), Hetero Healthcare Limited is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each.
-
Cipla to price generic version of COVID-19 drug remdesivir at less than Rs 5,000 per vial
Business | June 23, 2020 21:03 ISTPharma major Cipla will price its generic version of antiviral drug remdesivir at less than Rs 5,000 per vial in keeping with its conviction of providing access to the medicines at affordable cost, the company said on Tuesday.
-
Remdesiver, Favipiravir antiviral drugs 'no game changers' in COVID-19 fight, say medical experts
India | June 22, 2020 23:06 ISTWith pharmaceutical companies launching generic versions of Remdesivir and Favipiravir for COVID-19 treatment, medical experts on Monday said it was a "positive development" in the fight against the pandemic, but cautioned against regarding the antiviral drugs as "game changers".
-
Cipla launches generic remdesivir for COVID-19 patients
India | June 21, 2020 23:28 ISTHomegrown pharma major Cipla Ltd announced the launch of its generic version of remdesivir, which has been authorised for emergency use in the treatment of COVID-19 patients by the USFDA, under its brand name Cipremi.
-
Hetero gets DCGI nod to launch COVID-19 drug
Business | June 21, 2020 15:07 ISTDrug firm Hetero on Sunday said it has received approval from regulator DCGI to launch investigational antiviral drug Remdesivir for the treatment of COVID-19.
-
Health ministry recommends remdesivir for moderate cases, HCQ for early course of COVID-19
India | June 13, 2020 19:28 ISTThe Health Ministry on Saturday recommended the use of antiviral drug remdesivir in a moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the anti-malarial drug should be used in the early course of the disease and not on critically ill patients.
-
Dr Reddy's inks pact with Gilead Sciences for Remdesivir
India | June 13, 2020 16:38 ISTDr. Reddy's Laboratories Ltd on Saturday announced it has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. that will grant the city-based drug maker right to register, manufacture and sell Gilead's investigational drug, Remdesivir
-
Zydus Cadila inks licensing pact with Gilead for remdesivir
Business | June 12, 2020 21:16 ISTDrug firm Zydus Cadila on Friday said it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distribution of remdesivir, a potential therapy for COVID-19.
-
Remdesivir, tocilizumab being considered for 'restricted use' on severely ill COVID-19 patients
India | June 11, 2020 16:46 ISTAnti-viral drug remdesivir and tocilizumab, an immunomodulator, are being considered for "restricted use" on severely ill COVID-19 patients on "emergency and compassionate grounds", according to revised clinical management guidelines to be released soon.
-
Remdesivir improves time to recovery in COVID-19 patients: Study
Science | May 27, 2020 11:18 ISTRemdesivir, the antiviral under clinical trials for treatment against novel coronavirus infection, is superior to the standard of care given to COVID-19 patients, according to a new study.
Top News
-
Police seize jewellery, cash in Ram Temple donation theft probe; lawyers refuse to represent accused
-
India categorically rejects Pakistan's Karachi blast claims, says 'look inward, act against terror'
-
14 killed in Saudi Aramco helicopter crash near Ras Tanura, probe underway
-
Ben Stokes announces international retirement, Trent Bridge Test to be his last England appearance
Latest News
-
5 of a family killed after speeding car crashes into stationary container truck in Amravati
-
Smriti Mandhana, Shafali Verma shatter world record during IND vs AUS Women's T20 World Cup clash
-
Ben Stokes retires: 5 huge milestones of England icon as he walks into the sunset
-
Police seize jewellery, cash in Ram Temple donation theft probe; lawyers refuse to represent accused
-
Ben Stokes announces international retirement, Trent Bridge Test to be his last England appearance
-
Bengaluru auto driver explains how he uses ChatGPT every day. OpenAI responds with a fun reply
-
Office AC stopped working. What a group of Gen Z employees did next has the internet talking
-
Milk tanker overturns in Rajasthan; people rush with buckets and bottles
-
Why a sugarcane juice vendor's 'with ice' and 'without ice' pricing impressed a startup founder
-
Content creator applies tilak to strangers in Rishikesh. Here's how much he earned in 3 hours